Class information for:
Level 1: AMINOGLYCOSIDES//AMIKACIN//TOBRAMYCIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3868 1818 30.4 53%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
434 15650 CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMINOGLYCOSIDES Author keyword 24 15% 8% 144
2 AMIKACIN Author keyword 18 18% 5% 91
3 TOBRAMYCIN Author keyword 9 14% 3% 59
4 ONCE DAILY DOSING Author keyword 8 31% 1% 21
5 NETILMICIN Author keyword 7 26% 1% 25
6 EXTENDED INTERVAL DOSING Author keyword 5 63% 0% 5
7 ONCE DAILY DOSAGE Author keyword 4 75% 0% 3
8 ISEPAMICIN Author keyword 4 27% 1% 13
9 ONCE A DAY Author keyword 4 56% 0% 5
10 COMPUTERIZED DOSE PREDICTION Author keyword 3 100% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 AMINOGLYCOSIDES 24 15% 8% 144 Search AMINOGLYCOSIDES Search AMINOGLYCOSIDES
2 AMIKACIN 18 18% 5% 91 Search AMIKACIN Search AMIKACIN
3 TOBRAMYCIN 9 14% 3% 59 Search TOBRAMYCIN Search TOBRAMYCIN
4 ONCE DAILY DOSING 8 31% 1% 21 Search ONCE+DAILY+DOSING Search ONCE+DAILY+DOSING
5 NETILMICIN 7 26% 1% 25 Search NETILMICIN Search NETILMICIN
6 EXTENDED INTERVAL DOSING 5 63% 0% 5 Search EXTENDED+INTERVAL+DOSING Search EXTENDED+INTERVAL+DOSING
7 ONCE DAILY DOSAGE 4 75% 0% 3 Search ONCE+DAILY+DOSAGE Search ONCE+DAILY+DOSAGE
8 ISEPAMICIN 4 27% 1% 13 Search ISEPAMICIN Search ISEPAMICIN
9 ONCE A DAY 4 56% 0% 5 Search ONCE+A+DAY Search ONCE+A+DAY
10 COMPUTERIZED DOSE PREDICTION 3 100% 0% 3 Search COMPUTERIZED+DOSE+PREDICTION Search COMPUTERIZED+DOSE+PREDICTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NETILMICIN 80 51% 6% 112
2 DAILY NETILMICIN REGIMENS 53 95% 1% 18
3 AMINOGLYCOSIDE PLASMA LEVELS 50 67% 2% 45
4 AMINOGLYCOSIDE THERAPY 39 57% 3% 47
5 DAILY GENTAMICIN 38 78% 1% 25
6 PEAK CONCENTRATION 27 51% 2% 38
7 AMINOGLYCOSIDES 27 18% 8% 137
8 AMIKACIN 22 18% 6% 114
9 THRICE 21 90% 0% 9
10 PATIENTS RECEIVING AMINOGLYCOSIDES 20 66% 1% 19

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice 1997 124 63 92%
Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity 2011 28 31 65%
AMINOGLYCOSIDES - 50 YEARS ON 1995 156 61 79%
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses 1996 135 54 69%
Pharmacodynamics and dosing of aminoglycosides 2003 58 99 77%
Therapeutic Drug Monitoring of Aminoglycosides in Neonates 2009 28 59 76%
Aminoglycosides in Septic Shock 2013 10 153 65%
WHAT IS THE EVIDENCE FOR ONCE-DAILY AMINOGLYCOSIDE THERAPY 1994 70 82 85%
ONCE-DAILY AMINOGLYCOSIDE THERAPY 1991 245 49 59%
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis 2014 2 34 68%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ADC T 2 33% 0.3% 6
2 CHILD HLTH NOTTINGHAM P BIOMED UNIT 1 100% 0.1% 2
3 SAFE MEDICAT MANAGEMENT UNIT 1 50% 0.1% 2
4 SINA TEACHING HOSP 1 50% 0.1% 2
5 PHARMACOEPIDEMIOL EVALUAT IMPACT PROD SANTE POP 1 40% 0.1% 2
6 GRP HOSP GERIATRIE 1 25% 0.2% 3
7 EQUIPE ACCUEIL 645 1 33% 0.1% 2
8 319 COOKE HALL 1 50% 0.1% 1
9 ANSTALTS OTHEKE 1 50% 0.1% 1
10 ARKANSAS CYST FIBROSIS 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000245589 PHARMACEUT DEV DEV//QUALITY OF HEALTH CARE SERVICES//TEST PERFORMANCE CHARACTERISTICS
2 0.0000207279 POSTANTIBIOTIC EFFECT//POSTANTIBIOTIC SUB MIC EFFECT//POST ANTIBIOTIC EFFECT
3 0.0000187523 GENTAMICIN//GENTAMICIN INDUCED NEPHROTOXICITY//GENTAMICIN NEPHROTOXICITY
4 0.0000161508 BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV
5 0.0000143600 VET BASIC MED SCI//CYCLOSPORINE METABOLISM//DOSE REGIME
6 0.0000097600 DIHYDROSTREPTOMYCIN//ETIMICIN//COMPETITIVE DIRECT ELISA
7 0.0000089566 CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT
8 0.0000088049 VANCOMYCIN//TEICOPLANIN//FUNCEI
9 0.0000081203 SYRINGE PUMPS//GALEN HOSP PHARM//INFUSION LINE
10 0.0000071617 OTOTOXICITY//CISPLATIN OTOTOXICITY//OTOPROTECTION